Compare RXRX & BBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXRX | BBT |
|---|---|---|
| Founded | 2013 | 1846 |
| Country | United States | United States |
| Employees | N/A | 2050 |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 2021 | N/A |
| Metric | RXRX | BBT |
|---|---|---|
| Price | $3.11 | $30.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $7.50 | ★ $33.25 |
| AVG Volume (30 Days) | ★ 11.6M | 692.2K |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 4.26% |
| EPS Growth | ★ 14.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $74,681,000.00 | N/A |
| Revenue This Year | $12.11 | $77.88 |
| Revenue Next Year | $82.52 | $4.31 |
| P/E Ratio | ★ N/A | $29.98 |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.80 | $22.81 |
| 52 Week High | $7.18 | $32.00 |
| Indicator | RXRX | BBT |
|---|---|---|
| Relative Strength Index (RSI) | 40.42 | 56.80 |
| Support Level | $2.98 | $29.17 |
| Resistance Level | $5.03 | $30.40 |
| Average True Range (ATR) | 0.17 | 0.72 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 42.57 | 83.76 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.